Trending Down-0.2100 (-2.7167%)
  • Bid / Lots
    7.5800/ 1
  • Ask / Lots
    9.8800/ 1
  • Open / Previous Close
    7.6800 / 7.7300
  • Day Range
    Low 7.4710
    High 7.9000
  • 52 Week Range
    Low 6.8500
    High 21.1400
  • Volume
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 7.73
09:32 ET57467.68
09:36 ET2657.6591
09:41 ET20747.59
09:45 ET25007.5104
09:50 ET2007.56
09:52 ET1007.55
09:54 ET15007.55
10:01 ET1007.53
10:14 ET5557.4801
10:15 ET2007.5
10:21 ET15007.62
10:24 ET1007.635
10:42 ET35437.62
10:44 ET49687.56
10:46 ET66207.5122
10:51 ET2007.69
10:55 ET2407.56
11:02 ET3007.59
11:04 ET8007.69
11:11 ET1007.6063
11:18 ET6007.59
11:22 ET5007.585
11:24 ET1977.57
11:29 ET7007.57
11:42 ET3007.5782
11:44 ET1007.5799
11:49 ET3007.52
11:56 ET1007.52
12:07 ET10617.5
12:14 ET6697.4868
12:32 ET3007.471
12:48 ET98777.57
12:50 ET19007.54
12:54 ET2007.6
01:01 ET49567.6398
01:15 ET2007.9
01:37 ET1007.65
01:39 ET4257.63
01:46 ET4007.65
01:53 ET1007.6
02:13 ET52297.55
02:56 ET1007.7
03:14 ET9857.59
03:16 ET3007.5705
03:43 ET1007.525
03:45 ET2007.54
03:48 ET4617.505
03:54 ET51007.51
03:57 ET3007.51
03:59 ET41957.52
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTFFP
TFF Pharmaceuticals Inc
United StatesADVM
Adverum Biotechnologies Inc
United StatesCRVS
Corvus Pharmaceuticals Inc
United StatesAPTO
Aptose Biosciences Inc
United StatesPHAS
PhaseBio Pharmaceuticals Inc
United StatesGALT
Galectin Therapeutics Inc
As of 2021-10-23

Company Information

TFF Pharmaceuticals, Inc. is an early stage biopharmaceutical company. The Company is focused on developing and commercializing drug products based on its Thin Film Freezing (TFF) technology platform. Its TFF platform is designed to enable solubility of poorly water-soluble drugs. Its drug candidates include TFF Voriconazole Inhalation Powder (VIP), TFF Tacrolimus Inhalation Powder (TIP) and Triple Combination. It is developing TFF VIP to treat invasive pulmonary aspergillosis (IPA), a severe fungal pulmonary disease. TFF VIP is being developed as an inhaled dry powder drug. It is developing TFF TIP, a dry powder version of Tacrolimus, an immunosuppressive drug used in transplant medicine. It is developing Triple Combination, a dry powder drug combination to treat chronic obstructive pulmonary disease (COPD) and asthma. Its other dry powder products include Inhaled SARS-CoV2 Monoclonal Antibody, Niclosamide Inhalation Powder, Cannabidiol (CBD) and Vaccines.

Contact Information

2600 Via Fortuna Ste 360AUSTIN, TX, United States 78746-7983


No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.